|
Mission
Business
Model
Leadership
Advisory
Board
Investor
Relations

We look at important health and wellness
issues that haven't been adequately addressed --
to see if they can.
|
Mission &
Objective
Sensory Arts & Science develops sensory
testing and measurement products that provide
better ways to detect and objectively measure the
level of severity of conditions and diseases that
affect the human senses. The center of of these
sensory functions are the
12 cranial nerves.
Our prevention and early intervention approach
helps ensure better outcomes and reduced overall
incidence, and therefore the associated cost of
care.
We model our business and innovation process
after the wisdom of prolific inventor and
founding father Benjamin Franklin. While
prevention is always our first goal, we believe
that early detection and the ability to measure
or quantify a condition is usually the next best
thing.
Our principal objective is to develop:
- A comprehensive set of tools for managing the
occurrence, severity, and duration of certain
targeted health and safety issues and
conditions;
- In conjunction with healthcare experts and
opinion leaders, and peer reviewed by key
industry participants;
- Whose value proposition involves prevention
and early detection, thereby reducing incidence
and cost, increasing the likelihood of full
recovery, and improving outcomes and therefore
quality of life.
We strive to create technologies and products
that address important and unmet needs in diseases
and conditions that affect broad population
segments in our global community, thereby creating
sustainable value for our stakeholders and
partners.
Our Business Model
Our business model can be generally described as
a continuous innovation-to-commercialization
process. Health screening and disease management
technologies are conceived, followed by a process
to prove the viability of the concept and then to
protect the resulting Intellectual Property.
Based on the outcome of this proof of concept
phase, we will build, test, and commercialize a
product or technology that can then be licensed
to a partner with market reach, or we will
construct and launch a new company specifically
around the new product or technology.
Our innovation model is simple and elegant, and a
proven way to create sustainable value and
competitive advantage.
Leadership
Dave Davis, Managing Partner
Dave is the founder of Sensory Arts &
Science, with more than 30 years of healthcare,
corporate IT management and entrepreneurial
experience. Over the last 20 years, Dave has
founded and led several successful technology
ventures, including companies in systems
integration, healthcare technology, and
Internet/new media. Throughout his career, Dave
has provided management and strategic consulting
services to some of America's most prestigious
companies and has been a featured speaker on
topics such as technology futures and
entrepreneurship. Dave earned a Bachelor's Degree
in Business Administration from Ursinus College,
and is the holder of several issued and pending patents.
Dave leads the organization, defining its vision
and strategy, and building a team and strategic
relationships that enable the Company to fulfill
its plan and vision for leadership in the area of
sensory health and disease management
technologies.
Steve Rogers, Partner
Steve is a senior healthcare executive with more
than 25 years of healthcare business and
technology experience. Prior to Sensory Arts, he
was the principal of a healthcare consulting firm
specializing in executive outsourcing and
short-term consulting services to managed care
and healthcare companies. Steve was the Regional
President and Corporate Vice President for CIGNA
Healthplans in both New York and New Jersey,
playing a key role in the advancement of the
country’s first Point-of Service benefit program
with Allied-Signal Corp. He was also with US
Healthcare for 10 years as Vice President Medical
Delivery, VP of Operations, and, VP of Marketing.
Steve holds degrees from the University of
Maryland and the University of Baltimore Law
School
Medical/Scientific Advisory
Board
Peter
Febbroriello
Peter’s background is varied and fascinating. He
is the founder and principal of the Research
Support Group, where he provides a range of
R&D services to companies large and small.
His background includes significant work and
achievement in mechanical, electrical, and
bio-medical engineering. He has authored a number
of important studies in biophysics and
biochemistry, and has recently provided R&D
assistance to the University of Connecticut
Health Center, Knolls Atomic Power Laboratory,
and General Electric. Peter holds a Bachelor's
Degree in Biology/Pre-Med from University of
Connecticut.
Avery Gilbert,
Ph.D.
Dr. Gilbert is a sensory psychologist
specializing in odor perception, with over 16
years experience in the field of human olfaction.
He is currently President of Synesthetics, Inc.,
a multisensory research and consulting company
specializing in the consumer impact of smell. He
is the former President of the Sense of Smell
Institute, a not-for-profit organization and
global resource for the olfactory sense. Avery is
also the former Vice President of Sensory
Psychology at Givaudan Roure Fragrances, and a
faculty member at the Monell Chemical Senses
Center.
Michael Jones,
Ph.D.
Dr. Jones specializes in computer vision,
virtual reality, and Artificial Intelligence. After
receiving his Ph.D. in Computer Vision from the
University of Manchester, Dr. Jones performed
landmark research in the area of super-computing
vector algorithms and simulation. Most recently, he
has worked as an independent consultant to various
firms, and has developed advanced technologies for
3-d modeling and web-based expert systems.
Aureliu Porumbescu,
Ph.D.
Dr. Porumbescu holds a Ph.D. in Electrical
Engineering and System Science from the Polytechnic
University of Bucharest and an M.S. from
Polytechnic University of New York. He also has a
Courtesy Assistantship in Biotechnology at
University of Florida. For the last seven years,
Dr. Porumbescu has been President of Array Vision
Engineering and Proactive Metabolics. Prior to that
he spent five years as Corporate Vice President
with Invacare Corp. His technical career includes
ten years of advanced electro-optics and nuclear
spectroscopy work with Schlumberger in Princeton,
ITT in Fort Wayne, and Varian in Palo Alto for
developing military and aerospace devices and
systems.
Robert C. Sergott,
M.D.
Dr. Sergott is Co-Director and Attending
Surgeon of the Neuro-Ophthalmology Service at Wills
Eye Hospital in Philadelphia. He was named several
times to the list of the Best Doctors in
America and has authored more than 120
scientific papers, and lectured throughout the
U.S., Europe, South America, and Middle East. His
work also spans the technology industry, including
having run Siemens World Research Center for
Ophthalmic Color Doppler Studies. Dr. Sergott
received his undergraduate and M.D. degrees from
Johns Hopkins University.
Jeff Vachon
Jeff is National Sales Director for Philips
Medical Systems of Canada. His broad experience
within this market has enabled Jeff to work with
companies investigating and planning market
strategies, medical product development, and
working with various medical customers and
corporate clients. Jeff was formerly Vice
President, Business Development for Cifra Medical,
a pioneer in remote healthcare delivery and
Director, Business Development for Siemens Medical
Systems.
Investor Relations
Sensory Arts & Science is a privately held,
self-financed company. From time to time, the
company offers financial participation in
products or projects that would benefit from
strategic partnerships or require significant
resources to successfully develop and
commercialize. We prefer to work with strategic
investors, whether companies or individuals.
For more information on current opportunities and
participation, please contact Dave Davis, Managing Partner.
|
|